Blockade of the amino acid transporter SLC6A14 suppresses tumor growth in colorectal Cancer

Abstract Background The amino acid transporter SLC6A14, which transports 18 of the 20 proteinogenic amino acids, is too low to be detected in healthy normal tissues but is significantly increased in some solid cancers. However, little is known about the roles of SLC6A14 in colorectal cancer (CRC). M...

Full description

Bibliographic Details
Main Authors: Ying Lu, Ziting Jiang, Kaijing Wang, Shanshan Yu, Chongbo Hao, Zuan Ma, Xuelian Fu, Ming Qing Qin, Zengguang Xu, Lieying Fan
Format: Article
Language:English
Published: BMC 2022-07-01
Series:BMC Cancer
Subjects:
Online Access:https://doi.org/10.1186/s12885-022-09935-0
_version_ 1811222880346701824
author Ying Lu
Ziting Jiang
Kaijing Wang
Shanshan Yu
Chongbo Hao
Zuan Ma
Xuelian Fu
Ming Qing Qin
Zengguang Xu
Lieying Fan
author_facet Ying Lu
Ziting Jiang
Kaijing Wang
Shanshan Yu
Chongbo Hao
Zuan Ma
Xuelian Fu
Ming Qing Qin
Zengguang Xu
Lieying Fan
author_sort Ying Lu
collection DOAJ
description Abstract Background The amino acid transporter SLC6A14, which transports 18 of the 20 proteinogenic amino acids, is too low to be detected in healthy normal tissues but is significantly increased in some solid cancers. However, little is known about the roles of SLC6A14 in colorectal cancer (CRC). Methods The mRNA and protein levels of SLC6A14 were detected using TCGA database, real-time polymerase chain reaction, western blot, and tissue microarrays, respectively. Amino acids concentration was determined by LC-MS/MS. Cell proliferation and apoptosis were determined using MTT assay and flow cytometry. Transwell invasion assay and wound healing assay were employed to analyze cell migration and invasion. The protein levels of Akt-mTOR signaling pathway and MMPs proteins were detected by western blot. Results Both of the mRNA and protein levels of SLC6A14 were upregulated in CRC tissues, and the protein levels of SLC6A14 were closely related to the tumor cells differentiation: the higher the expression of SLC6A14 was, the poorer the differentiation of the tumor cells was. Further knockdown SLC6A14 with siRNA or treatment with α-MT in CRC cell lines reduced cell proliferation and migration in vitro and inhibited xenograft tumor growth in vivo. Mechanistically, SLC6A14 was demonstrated to regulate the expression and phosphorylation of Akt-mTOR, which mediates the promoting tumor growth function of SLC6A14. Blockade of SLC6A14 with α-MT inhibited the activation of mTOR signaling. Conclusion SLC6A14 was upregulated in CRC and could promote tumor progression by activating the Akt-mTOR signaling pathway, which may serve as an effective molecular target for the treatment of CRC.
first_indexed 2024-04-12T08:23:19Z
format Article
id doaj.art-a82f3eec58b243e996d6f3e481bb1759
institution Directory Open Access Journal
issn 1471-2407
language English
last_indexed 2024-04-12T08:23:19Z
publishDate 2022-07-01
publisher BMC
record_format Article
series BMC Cancer
spelling doaj.art-a82f3eec58b243e996d6f3e481bb17592022-12-22T03:40:30ZengBMCBMC Cancer1471-24072022-07-0122111610.1186/s12885-022-09935-0Blockade of the amino acid transporter SLC6A14 suppresses tumor growth in colorectal CancerYing Lu0Ziting Jiang1Kaijing Wang2Shanshan Yu3Chongbo Hao4Zuan Ma5Xuelian Fu6Ming Qing Qin7Zengguang Xu8Lieying Fan9Research Center for Translational Medicine, Shanghai East Hospital, School of Medicine, Tongji UniversityDepartment of Endoscopy, Fudan University Shanghai Cancer Center; Department of Oncology, Shanghai Medical College, Fudan UniversityResearch Center for Translational Medicine, Shanghai East Hospital, School of Medicine, Tongji UniversityDepartment of Clinical Laboratory, Shanghai East Hospital, School of Medicine, Tongji UniversityResearch Center for Translational Medicine, Shanghai East Hospital, School of Medicine, Tongji UniversityResearch Center for Translational Medicine, Shanghai East Hospital, School of Medicine, Tongji UniversityResearch Center for Translational Medicine, Shanghai East Hospital, School of Medicine, Tongji UniversityResearch Center for Translational Medicine, Shanghai East Hospital, School of Medicine, Tongji UniversityResearch Center for Translational Medicine, Shanghai East Hospital, School of Medicine, Tongji UniversityDepartment of Clinical Laboratory, Shanghai East Hospital, School of Medicine, Tongji UniversityAbstract Background The amino acid transporter SLC6A14, which transports 18 of the 20 proteinogenic amino acids, is too low to be detected in healthy normal tissues but is significantly increased in some solid cancers. However, little is known about the roles of SLC6A14 in colorectal cancer (CRC). Methods The mRNA and protein levels of SLC6A14 were detected using TCGA database, real-time polymerase chain reaction, western blot, and tissue microarrays, respectively. Amino acids concentration was determined by LC-MS/MS. Cell proliferation and apoptosis were determined using MTT assay and flow cytometry. Transwell invasion assay and wound healing assay were employed to analyze cell migration and invasion. The protein levels of Akt-mTOR signaling pathway and MMPs proteins were detected by western blot. Results Both of the mRNA and protein levels of SLC6A14 were upregulated in CRC tissues, and the protein levels of SLC6A14 were closely related to the tumor cells differentiation: the higher the expression of SLC6A14 was, the poorer the differentiation of the tumor cells was. Further knockdown SLC6A14 with siRNA or treatment with α-MT in CRC cell lines reduced cell proliferation and migration in vitro and inhibited xenograft tumor growth in vivo. Mechanistically, SLC6A14 was demonstrated to regulate the expression and phosphorylation of Akt-mTOR, which mediates the promoting tumor growth function of SLC6A14. Blockade of SLC6A14 with α-MT inhibited the activation of mTOR signaling. Conclusion SLC6A14 was upregulated in CRC and could promote tumor progression by activating the Akt-mTOR signaling pathway, which may serve as an effective molecular target for the treatment of CRC.https://doi.org/10.1186/s12885-022-09935-0SLC6A14Colorectal cancerAmino acid transporterα-MethyltryptophanmTOR
spellingShingle Ying Lu
Ziting Jiang
Kaijing Wang
Shanshan Yu
Chongbo Hao
Zuan Ma
Xuelian Fu
Ming Qing Qin
Zengguang Xu
Lieying Fan
Blockade of the amino acid transporter SLC6A14 suppresses tumor growth in colorectal Cancer
BMC Cancer
SLC6A14
Colorectal cancer
Amino acid transporter
α-Methyltryptophan
mTOR
title Blockade of the amino acid transporter SLC6A14 suppresses tumor growth in colorectal Cancer
title_full Blockade of the amino acid transporter SLC6A14 suppresses tumor growth in colorectal Cancer
title_fullStr Blockade of the amino acid transporter SLC6A14 suppresses tumor growth in colorectal Cancer
title_full_unstemmed Blockade of the amino acid transporter SLC6A14 suppresses tumor growth in colorectal Cancer
title_short Blockade of the amino acid transporter SLC6A14 suppresses tumor growth in colorectal Cancer
title_sort blockade of the amino acid transporter slc6a14 suppresses tumor growth in colorectal cancer
topic SLC6A14
Colorectal cancer
Amino acid transporter
α-Methyltryptophan
mTOR
url https://doi.org/10.1186/s12885-022-09935-0
work_keys_str_mv AT yinglu blockadeoftheaminoacidtransporterslc6a14suppressestumorgrowthincolorectalcancer
AT zitingjiang blockadeoftheaminoacidtransporterslc6a14suppressestumorgrowthincolorectalcancer
AT kaijingwang blockadeoftheaminoacidtransporterslc6a14suppressestumorgrowthincolorectalcancer
AT shanshanyu blockadeoftheaminoacidtransporterslc6a14suppressestumorgrowthincolorectalcancer
AT chongbohao blockadeoftheaminoacidtransporterslc6a14suppressestumorgrowthincolorectalcancer
AT zuanma blockadeoftheaminoacidtransporterslc6a14suppressestumorgrowthincolorectalcancer
AT xuelianfu blockadeoftheaminoacidtransporterslc6a14suppressestumorgrowthincolorectalcancer
AT mingqingqin blockadeoftheaminoacidtransporterslc6a14suppressestumorgrowthincolorectalcancer
AT zengguangxu blockadeoftheaminoacidtransporterslc6a14suppressestumorgrowthincolorectalcancer
AT lieyingfan blockadeoftheaminoacidtransporterslc6a14suppressestumorgrowthincolorectalcancer